 Seth Septer
Concepts (157)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adenomatous Polyposis Coli | 8 | 2022 | 40 | 2.550 |
Why?
| | Adenomatous Polyposis Coli Protein | 2 | 2018 | 20 | 1.020 |
Why?
| | Genetic Counseling | 2 | 2016 | 80 | 0.930 |
Why?
| | Hepatoblastoma | 3 | 2019 | 52 | 0.590 |
Why?
| | Dentofacial Deformities | 1 | 2018 | 1 | 0.550 |
Why?
| | Osteosclerosis | 1 | 2018 | 2 | 0.550 |
Why?
| | Osteoma | 1 | 2018 | 2 | 0.550 |
Why?
| | Mandibular Neoplasms | 1 | 2018 | 22 | 0.540 |
Why?
| | Intestinal Polyposis | 2 | 2019 | 7 | 0.530 |
Why?
| | Endoscopy, Gastrointestinal | 3 | 2016 | 237 | 0.520 |
Why?
| | Genetic Testing | 3 | 2019 | 483 | 0.520 |
Why?
| | Neoplastic Syndromes, Hereditary | 2 | 2019 | 47 | 0.510 |
Why?
| | Counselors | 1 | 2016 | 10 | 0.490 |
Why?
| | Genes, APC | 2 | 2019 | 11 | 0.490 |
Why?
| | Polyps | 1 | 2013 | 14 | 0.380 |
Why?
| | Chromosomes, Human, Pair 10 | 1 | 2013 | 20 | 0.380 |
Why?
| | Esophageal Diseases | 1 | 2013 | 30 | 0.380 |
Why?
| | Esophagitis | 1 | 2013 | 67 | 0.370 |
Why?
| | Chromosome Deletion | 1 | 2013 | 126 | 0.370 |
Why?
| | Liver Neoplasms | 2 | 2016 | 777 | 0.360 |
Why?
| | Mutation | 4 | 2018 | 4090 | 0.330 |
Why?
| | Early Detection of Cancer | 1 | 2016 | 486 | 0.330 |
Why?
| | Esophagus | 1 | 2013 | 262 | 0.330 |
Why?
| | Barrett Esophagus | 1 | 2013 | 169 | 0.320 |
Why?
| | Phosphoproteins | 1 | 2011 | 337 | 0.300 |
Why?
| | Genetic Predisposition to Disease | 2 | 2015 | 2399 | 0.290 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2011 | 426 | 0.280 |
Why?
| | Biomarkers, Tumor | 1 | 2015 | 1329 | 0.270 |
Why?
| | Liver | 2 | 2018 | 1899 | 0.260 |
Why?
| | Colectomy | 2 | 2016 | 106 | 0.200 |
Why?
| | Child | 13 | 2022 | 22740 | 0.190 |
Why?
| | Radiography, Panoramic | 2 | 2021 | 14 | 0.180 |
Why?
| | Child, Preschool | 6 | 2019 | 11868 | 0.170 |
Why?
| | Infant | 6 | 2016 | 10091 | 0.150 |
Why?
| | Cromolyn Sodium | 1 | 2018 | 6 | 0.140 |
Why?
| | Colonoscopy | 3 | 2019 | 264 | 0.140 |
Why?
| | Polycystic Kidney, Autosomal Recessive | 1 | 2018 | 6 | 0.140 |
Why?
| | Colonic Polyps | 1 | 2019 | 88 | 0.140 |
Why?
| | Cell Degranulation | 1 | 2018 | 40 | 0.140 |
Why?
| | Craniopharyngioma | 1 | 2019 | 77 | 0.140 |
Why?
| | Jaw | 1 | 2018 | 27 | 0.130 |
Why?
| | Pituitary Neoplasms | 1 | 2019 | 190 | 0.130 |
Why?
| | Cell Proliferation | 2 | 2017 | 2514 | 0.130 |
Why?
| | beta Catenin | 1 | 2019 | 254 | 0.130 |
Why?
| | Polycystic Kidney Diseases | 1 | 2017 | 71 | 0.120 |
Why?
| | Mast Cells | 1 | 2018 | 148 | 0.120 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2017 | 187 | 0.120 |
Why?
| | Prophylactic Surgical Procedures | 1 | 2016 | 7 | 0.120 |
Why?
| | Duodenal Neoplasms | 1 | 2016 | 26 | 0.120 |
Why?
| | Chemoprevention | 1 | 2016 | 92 | 0.120 |
Why?
| | Adolescent | 7 | 2019 | 22577 | 0.120 |
Why?
| | Capsule Endoscopy | 1 | 2015 | 25 | 0.110 |
Why?
| | Microbiota | 1 | 2022 | 730 | 0.110 |
Why?
| | Prevalence | 2 | 2021 | 2875 | 0.110 |
Why?
| | Genetic Diseases, Inborn | 1 | 2014 | 45 | 0.100 |
Why?
| | Lymphoproliferative Disorders | 1 | 2014 | 59 | 0.100 |
Why?
| | Humans | 17 | 2022 | 145785 | 0.100 |
Why?
| | Male | 10 | 2019 | 73012 | 0.100 |
Why?
| | Failure to Thrive | 1 | 2013 | 28 | 0.100 |
Why?
| | Bone Morphogenetic Protein Receptors, Type I | 1 | 2013 | 10 | 0.100 |
Why?
| | STAT3 Transcription Factor | 1 | 2014 | 206 | 0.090 |
Why?
| | Stomach | 1 | 2013 | 111 | 0.090 |
Why?
| | Pediatrics | 3 | 2019 | 1125 | 0.090 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2013 | 80 | 0.090 |
Why?
| | Vomiting | 1 | 2013 | 131 | 0.090 |
Why?
| | Self Report | 1 | 2016 | 876 | 0.090 |
Why?
| | Thyroid Neoplasms | 1 | 2016 | 370 | 0.090 |
Why?
| | Colorectal Neoplasms | 2 | 2019 | 868 | 0.090 |
Why?
| | Ion Transport | 1 | 2011 | 62 | 0.090 |
Why?
| | Gastritis | 1 | 2013 | 117 | 0.090 |
Why?
| | Abdominal Pain | 1 | 2013 | 149 | 0.090 |
Why?
| | Female | 10 | 2019 | 79045 | 0.090 |
Why?
| | PTEN Phosphohydrolase | 1 | 2013 | 165 | 0.090 |
Why?
| | Phenotype | 3 | 2019 | 3170 | 0.090 |
Why?
| | Deglutition Disorders | 1 | 2013 | 154 | 0.080 |
Why?
| | Epithelial Cells | 1 | 2017 | 1135 | 0.080 |
Why?
| | Treatment Outcome | 3 | 2016 | 11794 | 0.080 |
Why?
| | Tretinoin | 1 | 2011 | 125 | 0.080 |
Why?
| | Cell Cycle Proteins | 2 | 2011 | 630 | 0.080 |
Why?
| | Organ Size | 1 | 2011 | 461 | 0.080 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2011 | 267 | 0.080 |
Why?
| | Bile Acids and Salts | 1 | 2011 | 163 | 0.080 |
Why?
| | Collagen | 1 | 2013 | 457 | 0.080 |
Why?
| | Autoimmune Diseases | 1 | 2014 | 469 | 0.080 |
Why?
| | Kidney | 1 | 2018 | 1497 | 0.080 |
Why?
| | Case-Control Studies | 1 | 2018 | 3634 | 0.080 |
Why?
| | Mass Screening | 1 | 2019 | 1361 | 0.080 |
Why?
| | Retrospective Studies | 3 | 2019 | 17330 | 0.070 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2011 | 373 | 0.070 |
Why?
| | Optic Neuritis | 1 | 2008 | 44 | 0.070 |
Why?
| | Bronchiolitis | 1 | 2008 | 87 | 0.060 |
Why?
| | Pneumonia, Bacterial | 1 | 2008 | 113 | 0.060 |
Why?
| | Feeding and Eating Disorders | 1 | 2008 | 165 | 0.060 |
Why?
| | Mice, Inbred C57BL | 2 | 2017 | 5995 | 0.060 |
Why?
| | Biopsy | 2 | 2022 | 1082 | 0.050 |
Why?
| | Gene Expression Profiling | 1 | 2011 | 1777 | 0.050 |
Why?
| | Cell Differentiation | 1 | 2011 | 2050 | 0.050 |
Why?
| | Apoptosis | 1 | 2011 | 2445 | 0.050 |
Why?
| | Rats, Sprague-Dawley | 2 | 2018 | 2525 | 0.040 |
Why?
| | Adult | 4 | 2021 | 40882 | 0.040 |
Why?
| | Clinical Competence | 1 | 2008 | 1247 | 0.040 |
Why?
| | Young Adult | 2 | 2013 | 14254 | 0.040 |
Why?
| | Gastrointestinal Neoplasms | 1 | 2019 | 73 | 0.040 |
Why?
| | Gastrointestinal Hemorrhage | 1 | 2019 | 138 | 0.030 |
Why?
| | Point Mutation | 1 | 2019 | 241 | 0.030 |
Why?
| | Germ-Line Mutation | 1 | 2019 | 177 | 0.030 |
Why?
| | Tumor Microenvironment | 1 | 2022 | 735 | 0.030 |
Why?
| | Connective Tissue Growth Factor | 1 | 2017 | 27 | 0.030 |
Why?
| | Animals | 3 | 2018 | 38106 | 0.030 |
Why?
| | Disease Models, Animal | 2 | 2018 | 4568 | 0.030 |
Why?
| | Consensus | 1 | 2019 | 479 | 0.030 |
Why?
| | Age Factors | 2 | 2015 | 3346 | 0.030 |
Why?
| | Adenoma | 1 | 2019 | 218 | 0.030 |
Why?
| | Gastroenterology | 1 | 2019 | 191 | 0.030 |
Why?
| | RNA Interference | 1 | 2017 | 475 | 0.030 |
Why?
| | Electronic Mail | 1 | 2015 | 60 | 0.030 |
Why?
| | Evidence-Based Medicine | 1 | 2019 | 740 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2022 | 2968 | 0.030 |
Why?
| | STAT5 Transcription Factor | 1 | 2014 | 50 | 0.030 |
Why?
| | STAT1 Transcription Factor | 1 | 2014 | 66 | 0.030 |
Why?
| | Mice | 1 | 2011 | 18358 | 0.030 |
Why?
| | Canada | 1 | 2015 | 432 | 0.030 |
Why?
| | Health Care Surveys | 1 | 2015 | 536 | 0.020 |
Why?
| | Dyspepsia | 1 | 2013 | 11 | 0.020 |
Why?
| | Gastric Mucosa | 1 | 2013 | 54 | 0.020 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2019 | 1150 | 0.020 |
Why?
| | Needs Assessment | 1 | 2015 | 403 | 0.020 |
Why?
| | Gene Expression | 1 | 2017 | 1478 | 0.020 |
Why?
| | Anemia, Iron-Deficiency | 1 | 2013 | 62 | 0.020 |
Why?
| | Disease Progression | 1 | 2019 | 2865 | 0.020 |
Why?
| | Tissue Array Analysis | 1 | 2011 | 49 | 0.020 |
Why?
| | Fellowships and Scholarships | 1 | 2015 | 354 | 0.020 |
Why?
| | Bile Ducts, Intrahepatic | 1 | 2011 | 63 | 0.020 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2014 | 411 | 0.020 |
Why?
| | Gene Silencing | 1 | 2011 | 202 | 0.020 |
Why?
| | Cholangiocarcinoma | 1 | 2011 | 108 | 0.020 |
Why?
| | Phosphorylation | 1 | 2014 | 1708 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2017 | 3130 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2013 | 1043 | 0.020 |
Why?
| | Bile Duct Neoplasms | 1 | 2011 | 131 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2017 | 4151 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2021 | 5925 | 0.020 |
Why?
| | Cell Communication | 1 | 2011 | 327 | 0.020 |
Why?
| | Cell Survival | 1 | 2011 | 1105 | 0.020 |
Why?
| | Moraxellaceae Infections | 1 | 2008 | 3 | 0.020 |
Why?
| | Curriculum | 1 | 2015 | 1074 | 0.020 |
Why?
| | Sampling Studies | 1 | 2008 | 98 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2013 | 2123 | 0.020 |
Why?
| | Chronic Disease | 1 | 2013 | 1812 | 0.020 |
Why?
| | Nuclear Proteins | 1 | 2011 | 740 | 0.020 |
Why?
| | Adrenal Cortex Hormones | 1 | 2008 | 484 | 0.010 |
Why?
| | Internship and Residency | 1 | 2015 | 1269 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2011 | 3551 | 0.010 |
Why?
| | Transcription Factors | 1 | 2011 | 1736 | 0.010 |
Why?
| | Signal Transduction | 1 | 2011 | 5226 | 0.010 |
Why?
| | United States | 1 | 2015 | 16126 | 0.010 |
Why?
| | Anti-Bacterial Agents | 1 | 2008 | 1925 | 0.010 |
Why?
|
|
Septer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|